186 related articles for article (PubMed ID: 35409410)
1. shRNAs Targeting a Common
Cócera-Ortega L; Wilders R; Kamps SC; Fabrizi B; Huber I; van der Made I; van den Bout A; de Vries DK; Gepstein L; Verkerk AO; Pinto YM; Tijsen AJ
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409410
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
[TBL] [Abstract][Full Text] [Related]
3. Suppression-Replacement
Dotzler SM; Kim CSJ; Gendron WAC; Zhou W; Ye D; Bos JM; Tester DJ; Barry MA; Ackerman MJ
Circulation; 2021 Apr; 143(14):1411-1425. PubMed ID: 33504163
[TBL] [Abstract][Full Text] [Related]
4. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
5. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.
Amin AS; Giudicessi JR; Tijsen AJ; Spanjaart AM; Reckman YJ; Klemens CA; Tanck MW; Kapplinger JD; Hofman N; Sinner MF; Müller M; Wijnen WJ; Tan HL; Bezzina CR; Creemers EE; Wilde AA; Ackerman MJ; Pinto YM
Eur Heart J; 2012 Mar; 33(6):714-23. PubMed ID: 22199116
[TBL] [Abstract][Full Text] [Related]
6. NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
Ronchi C; Bernardi J; Mura M; Stefanello M; Badone B; Rocchetti M; Crotti L; Brink P; Schwartz PJ; Gnecchi M; Zaza A
Cardiovasc Res; 2021 Jan; 117(2):472-483. PubMed ID: 32061134
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.
Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651
[No Abstract] [Full Text] [Related]
8. A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.
Bartos DC; Giudicessi JR; Tester DJ; Ackerman MJ; Ohno S; Horie M; Gollob MH; Burgess DE; Delisle BP
Heart Rhythm; 2014 Mar; 11(3):459-68. PubMed ID: 24269949
[TBL] [Abstract][Full Text] [Related]
9. To Modify or Not to Modify: Allele-Specific Effects of 3'UTR-
Winbo A; Diamant UB; Persson J; Jensen SM; Rydberg A
J Am Heart Assoc; 2022 Sep; 11(18):e025981. PubMed ID: 36102229
[TBL] [Abstract][Full Text] [Related]
10. Studying KCNQ1 Mutation and Drug Response in Type 1 Long QT Syndrome Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Wei H; Wu J; Liu Z
Methods Mol Biol; 2018; 1684():7-28. PubMed ID: 29058180
[TBL] [Abstract][Full Text] [Related]
11. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2.
Giannetti F; Barbieri M; Shiti A; Casini S; Sager PT; Das S; Pradhananga S; Srinivasan D; Nimani S; Alerni N; Louradour J; Mura M; Gnecchi M; Brink P; Zehender M; Koren G; Zaza A; Crotti L; Wilde AAM; Schwartz PJ; Remme CA; Gepstein L; Sala L; Odening KE
Europace; 2023 May; 25(5):. PubMed ID: 37099628
[TBL] [Abstract][Full Text] [Related]
12. Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?
Crotti L; Lahtinen AM; Spazzolini C; Mastantuono E; Monti MC; Morassutto C; Parati G; Heradien M; Goosen A; Lichtner P; Meitinger T; Brink PA; Kontula K; Swan H; Schwartz PJ
Circ Cardiovasc Genet; 2016 Aug; 9(4):330-9. PubMed ID: 27531917
[TBL] [Abstract][Full Text] [Related]
13. Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.
Wang H; Guo T; Lan F
Stem Cell Res; 2023 Aug; 70():103119. PubMed ID: 37244124
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
[TBL] [Abstract][Full Text] [Related]
15. Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current.
Siebrands CC; Binder S; Eckhoff U; Schmitt N; Friederich P
Anesthesiology; 2006 Sep; 105(3):511-20. PubMed ID: 16931984
[TBL] [Abstract][Full Text] [Related]
16. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
[TBL] [Abstract][Full Text] [Related]
17. Using the genome aggregation database, computational pathogenicity prediction tools, and patch clamp heterologous expression studies to demote previously published long QT syndrome type 1 mutations from pathogenic to benign.
Clemens DJ; Lentino AR; Kapplinger JD; Ye D; Zhou W; Tester DJ; Ackerman MJ
Heart Rhythm; 2018 Apr; 15(4):555-561. PubMed ID: 29197658
[TBL] [Abstract][Full Text] [Related]
18. R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation.
Bartos DC; Duchatelet S; Burgess DE; Klug D; Denjoy I; Peat R; Lupoglazoff JM; Fressart V; Berthet M; Ackerman MJ; January CT; Guicheney P; Delisle BP
Heart Rhythm; 2011 Jan; 8(1):48-55. PubMed ID: 20850564
[TBL] [Abstract][Full Text] [Related]
19. Microscopic mechanisms for long QT syndrome type 1 revealed by single-channel analysis of I(Ks) with S3 domain mutations in KCNQ1.
Eldstrom J; Wang Z; Werry D; Wong N; Fedida D
Heart Rhythm; 2015 Feb; 12(2):386-94. PubMed ID: 25444851
[TBL] [Abstract][Full Text] [Related]
20. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Zhang H; Jahng JWS; Liu Y; Chase AJ; Perez MV; Wu JC
Stem Cell Res; 2021 Aug; 55():102492. PubMed ID: 34411974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
